1.IFN-? Release Assays for Rapid Diagnosis of Active Tuberculosis:Clinical Application
Hua ZHANG ; Shengwen HUANG ; Zhenyuan LUO
Chinese Journal of Nosocomiology 2009;0(14):-
OBJECTIVE To evaluate the clinical application of T-cell based IFN-? release assays(IGRA) for the rapid diagnosis of active tuberculosis.METHODS IFN-? and HIV antibody were detected by using ELISA.Antibody to Mycobacterium tuberculosis was detected by colloidal gold.At the same time,the M.tuberculosis DNA loads were examined by FQ-PCR.Statistical analysis were performed to analyze the correlation of IFN-? with M.tuberculosis antibody and DNA,respectively.RESULTS The sensitivity of TB-IGRA was 90.24%,specificity was 93.34%;the positive rate of TB-IGRA in 82 tuberculosis patients was higher than from sputum smear(64.63%),TB-PCR(76.83%) and tuberculosis antibody(40.24%).CONCLUSIONS As a replacement of TB-PCR,IFN-? can be used as a valued index to evaluate tuberculosis infectin.
2.Clinical study on the priming with colloid in extracorporeal circulation of the patients undergoing valve replacement
Jin LUO ; Jiachun LI ; Zhenyuan DING
Medical Journal of Chinese People's Liberation Army 1982;0(03):-
Objective To analyze and evaluate the effect addition of albumin to the extracorporeal circulation (CPB) in patients undergoing valve replacement. Methods 62 patients under 60 years of age, with the blood level of albumin nearly normal, undergoing mitral valve replacement or aortic valve replacement were randomly divided into two groups. In 34 patients albumin was added to the priming fluid of extraporeal circulation, and in 28 patients it was not. The pre-operative and postoperative serum albumin levels, the duration of assisting ventilation, and the amount of albumin needed between the time of operation to 7 am of the first postoperative day were compared. In both groups the primary priming fluid consisted of balanced electrolyte solution, hydroxyethyl starch, 5% sodium bicarbonate, and 25% mannitol. Results All the indexes, including the preoperative level of albumin, the amount of albumin needed from operation to 7 am of the first postoperative day, and the albumin level at 7 am of the first postoperative day showed no notable differences. Conclusion For patients with no hypoalbuminemia, mitral valve replacement or aortic valve replacement is safe to withhold the addition of albumin to the priming fluid for CPB.
3.Application of the pyrosequencing technique for detection of VKORC1 and CYP2C9 genotypes
Qin XU ; Shengwen HUANG ; Nannan YANG ; Shimin WANG ; Zhenyuan LUO ; Bangquan AN
International Journal of Laboratory Medicine 2018;39(7):769-772
Objective To establish genotyping methods for vitamin K epoxide reductase complex subunit 1 (VKORC1)and cytochrome P450 2C9(CYP2C9)based on pyrosequencing technique to detection of warfarin metabolizing enzyme related gene polymorphisms.Methods A total of 50 peripheral blood samples from healthy adults were collected and the whole blood genomic DNA was extracted.A set of biotin-labeled amplifi-cation primers and sequencing primers were designed respectively for three SNP sites:VKORC1 -1639 G>A,CYP2C9 430C> T and CYP2C9 1075A>C.After PCR amplification of the samples,pyrophosphoric acid se-quencing was conducted.And then the signal peaks form were combined to analyze and determine each sample genotype.Genotyping results were verified by Sanger sequencing,and the consistency of the two sequencing methods was compared.Results Genotypes of the three SNPs can be clearly determined according to the ba-ses and height of the signal peaks.Among the 50 samples,there were 41 AA and nine AG for VKORC1 -1639G>A,accounting for 82% and 12% respectively,and there were 45 *1/*1,five *1/*3 for CYP2C9, accounting for 90% and 10% respectively,no CYP2C9*2 allele detected.Genotype results detected by pyrose-quencing and Sanger sequencing were consistent with each other.Conclusion In SNP genotyping,Pyrose-quencing has the advantages of convenience,time-saving,cheap with accurate and reliable results,which can quickly determine the genotypes of CYP2C9 and VKORC1.
4.Analysis of deafness gene mutations by gene chip and its clinical significance.
Hua ZHANG ; Yuqing LIU ; Youqin WANG ; Guifang LI ; Zhenyuan LUO ; Peng fei JIANG ; Fei LI ; Shuhui WANG ; Kaixian DENG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;23(22):1032-1035
OBJECTIVE:
To analyze deafness gene mutations by genechip.
METHOD:
The peripheral blood samples were obtained and DNA templates were extracted by extraction kits. The deafness gene mutations were distinguished by genechip.
RESULT:
Among 42 patients with non-syndromic hearing loss, GJB2 235delC was found in 11 cases (7 cases were homozygosis, 4 cases were heterozygosis); 4 cases were shown to carry the PDS IVS7-2A>G mutation.
CONCLUSION
The incidence of GJB2 gene and PDS IVS7-2A>G mutations among the deaf- mute children in Guiyang city is 38.10%. Molecular genetic screening for these mutations and genetic counseling are effective methods to prevent the occurrence of hereditary hearing loss.
Adolescent
;
Child
;
Child, Preschool
;
China
;
Connexin 26
;
Connexins
;
genetics
;
Deafness
;
genetics
;
Genetic Testing
;
Humans
;
Infant
;
Membrane Transport Proteins
;
genetics
;
Mutation
;
Oligonucleotide Array Sequence Analysis
;
Sulfate Transporters
;
Surveys and Questionnaires
;
Young Adult
5.Design, synthesis and biological activity of non-nucleoside NEDD8-activating enzyme inhibitors
Chuan LUO ; Zhiliang YU ; Wannian ZHANG ; Zhenyuan MIAO
Journal of Pharmaceutical Practice 2020;38(1):35-41
Objective To develop novel NAE inhibitors with non-nucleoside scaffold by a scaffold hopping strategy and study the in vitro antitumor activities. Methods Disulfonamideindazole 14 was synthesized through 23 steps with a good yield. Its chemical structure was confirmed by 1H NMR and MS. MTT method was used to determine the in vitro antitumor activities. Results Compound 14 exhibited moderate antitumor activities against various cancer cells and promoted significant UBC12 accumulation in a dose-dependent manner. Conclusion Compound 14 is a potent NAE inhibitor with remarkable apoptosis induction and cell cycle arrest in prostate cancer PANC-1 cells. Our work provides a valuable leading compound for the further design and development of NAE inhibitors.
6.Discovery of bepridil as a valuable lead compound with potent p53-MDM2 inhibitory activity
Chuan LUO ; Jing LI ; Wannian ZHANG ; Zhenyuan MIAO
Journal of Pharmaceutical Practice 2021;39(2):126-129
Objective To find novel lead compounds as p53-MDM2 inhibitors by drug repurposing strategy. Methods The p53-MDM2 inhibitory activities of compounds were determined by FP and western blotting. MTT method was used to determine the in-vitro antitumor activities. The metabolites in human liver microsomes were tested. Results Bepridil showed excellent in-vitro anti-tumor activity and strong p53-MDM2 protein binding inhibitory activity, which can significantly reduce the expression of MDM2 protein in a dose-dependent manner. The metabolites in human liver microsomes are mainly benzene ring hydroxyl mono-oxidation metabolites. Conclusion Bepridil can be used as a lead compound for p53-MDM2 protein binding small molecule inhibitors for subsequent structural optimization design studies.
7.Design, synthesis and antitumor activity of 3-arenobufagin esters
Chuan LUO ; Jianjiang MA ; Zhenyuan MIAO ; Yuelin WU
Journal of Pharmaceutical Practice 2021;39(1):35-37
Objective To search for novel potent 3-ester derivatives of arenobufagin and test their antitumor activities in vitro. Methods Target compounds were synthesized by esterification of arenobufagin with acids. CellTiter method was used to assay the in vitro antitumor activities. Results 3-Ester derivatives exhibited excellent antitumor activities against all the cancer cells. Conclusion Among the 3-ester derivatives, compound 2a had the best activities with the IC50 of 4.0−91.7 nmol/L and appeared to be a valuable candidate for further study.
8.Research progress on risk prediction of cardiac arrest
Zhenyuan LI ; Maiying FAN ; Xiquan YAN ; Jieying LUO ; Yixiao XU ; Junwen SU ; Xiaotong HAN
Chinese Critical Care Medicine 2024;36(3):320-325
Cardiac arrest (CA) is a serious cardiac event, which has a high incidence and low survival rate at home and abroad. In order to predict the risk of CA in advance, a large number of studies have been conducted by relevant researchers. This paper mainly summarizes the characteristics and research status of the existing analysis and prediction of CA from three aspects: the risk prediction factors of CA, the evaluation index of risk prediction of CA and the early warning scoring system of CA. We hope it can help medical staff to understand the current progress in this field, and provide new ways and methods for predicting the risk of CA.